Sign in
8-K

Current Report

Protalix BioTherapeutics, Inc. Filed Acc 0001144204-17-061920

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading tv480506_8k.htm…